Research Highlights and Accomplishments


  • Innovative laboratory research that focuses on gene therapy, molecular therapy, cell signaling, nanomedicine and genomics
  • Ability to move laboratory findings from bench to bedside
  • Increasing research collaborations with local, national and international organizations
  • Designated research centers within Children’s Healthcare of Atlanta/Emory Department of Pediatrics  to support research advancements in pediatric cancer and blood disorders
  • Commitment to the future of pediatric hematology/oncology research through our fellowship program
  • 100 percent of our pediatric hematologist/oncologists are researchers as well
  • 100 percent of the patients treated at the Aflac Cancer Center are evaluated for participation in a clinical trial—our physicians are constantly looking for ways to apply learnings from research to improve the care of our patients
  • Offer enrollment in research studies that focus on childhood cancer survivorship and the late effect of treatment


  • Member of the Children's Oncology Group (COG) Phase I and Pilot Consortium—one of only 21 centers nationwide
  • Among the top five percent of institutions nationally for clinical trial enrollment for COG studies
  • Recipient of a $1 million, four-year EUREKA grant
  • One of the founding members of POETIC
  • Offer enrollment in exclusive Phase I and II studies for neuroblastoma and other cancers through our participation in POETIC and NANT
  • First Phase I clinical trial to test the concept of a "chemosensitization" approach in children using Plerixafor
  • One of only eight centers in the country awarded funds to participate in the NIH sponsored Sickle Cell Clinical Research Network; in collaboration with other national experts and treatment centers nationwide, we are conducting important clinical research studies that focus on improving the quality of life for kids with sickle cell disease
  • One of 17 sites in the country in the NIH-funded Transfusion Medicine and Hemostasis Research Network
  • Nationally and internationally recognized hemophilia treatment center with long-term success